Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Jaro1977on Aug 11, 2020 3:00pm

186 Views

Post# 31394195

RE:How can they just continue to ignore shareholders?????

RichieRich123

I think they are being extra cautious, quiet because in the past, projections and estimates were given that were misleading and underacheived. The last NR, while containing some unfortunate news (4 dropped, all undertreated), some great news (3 treated, 90 day CR), was very clinically written. A very precise overview of were they are at.

I hope we get an update today as I beleive the deadline to provide AGM agenda for voting is 21 days and the voting date is August 21st (20 days from now).

If this continues, I do agree with others that have posted that we get enough shareholders together to hold the board and management accountable.

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide